Skip to main content

Table 1 Patient demographics, clinical and radiological findings

From: Changing the paradigm of intracranial hypertension in brain tumor patients: a study based on non-invasive ICP measurements

Patient Number

GCS

Neurological deficits

Steroids

Clinical signs of ICH

Tumor location

Histology

Concomitand disease

Maximal tumor diameter (cm)

Tumor structure

Tumor volume (cm3)

Edema volume (cm3)

Midline shift

Hemorrhage

Hydrocephalus

Non-invasive absolute ICP left / right

1

15

apraxia, visual field restriction left side, vision impairement left side

no

none

Bilateral parafalcine occipital

Meningeoma Grade II

Hypertension

Diabetes mellitus

Typ II

4.7 × 5.4 × 8.1

solid with homogeneously contrast enhancement

106.226

151.439

2.5 mm

none

none

10.4 / 6

2

15

absences, focal seizures

no

none

Left frontal

Diffuse Astrocytoma Grade II

none

2.6 × 4.0 × 5.0

T2 hyperdens / T1 hypodens lesion without contrast enhancement

33.723

0.000

none

none

none

9.94 / 7.95

3

14

focal and secondarily generalized seizures

yes

none

Left temporal

Glioblastoma multiforme

Hypertension

Alcohol abuse

4.0 × 2.7 × 3.9

T2 hyperdens / T1 hypodens lesion without contrast enhancement

24.985

0.000

none

none

none

7.14 / 10.43

4

15

focal seizures

no

none

Multifocal (right thalamus, left parietal, right frontal right)

Astrocytoma Grade III - IV

Metabolic syndrome

GIST Tumor of the stomach

3.1 × 3.1 × 4.0

multifocal central necrotic lesion with margin contrast enhancement

30.217

89.075

3 mm

none

none

10.09 / 9.15

5

15

absences, memory disorders

yes

none

Left temporal

Meningeoma Grade I

none

2.5 × 3.1 × 2.5

solid with homogeneously contrast enhancement

10.306

115.310

5.3 mm

none

none

10.82 / -

6

15

gerstmann syndrome, aphasie

no

none

Left temporo-occipital

Metastasis

Renal cell carcinoma

1.9 × 2.0 × 2.2

central necrotic lesion with homogeneously contrast enhancement

5.450

67.337

none

yes

none

7.0 / -

7

15

vertigo

yes

headache, nausea, vomitting

Right cerebellum

Metastasis

Hypertension

Breast cancer

3.7 × 4.2 × 2.7

solid with moderate non homogeneously contrast enhancement

23.783

10.304

none

none

none

10.5 / 12.71

8

14

neglect, apraxia

no

none

Right parietal

Glioblastoma

multiforme

Metabolic Syndrom

Coronary heart disease

Cerebrovascular and peripheral occlusive disease

COPD

3.7 × 6.2 × 5.5

central necrotic lesion with margin contrast enhancement

62.100

47.995

2 mm

none

none

12.57 / 11.43

9

14

neurocognitive deficits

no

none

Bilateral frontal parafalcine

Meningeoma Grade I

none

5.7 × 4.6 × 5

solid with homogeneously contrast enhancement

56.933

0.000

9 mm

none

none

5.5 / 9.9

10

14

neurocognitive deficits

no

none

Left Temporal

Meningeoma Grade I

Metabolic Syndrom

Breast Cancer

Status following pulmonary embolism

3.9 × 3.5 × 2.8

solid with homogeneously contrast enhancement

23.421

2.325

none

none

none

10.45 / 16.72

11

15

none

yes

none

Right frontal

Meningeoma Grade I

Coronary heart disease

Status following pulmonary embolism

2.1 × 2.4 × 1.9

solid with homogeneously contrast enhancement

7.077

117.318

none

none

none

5.52 / 5.53

12

15

vertigo, unsteadiness, diplopia

yes

headache

Vermis cerebelli

Metastasis

Breast Cancer

4.2 × 3.7 × 3.8

solid with moderate contrast enhancement

25.550

36.790

none

none

yes

5.59 / 10.70

13

15

hemiplegia right side

yes

none

Left frontal

Metastasis

Prostate Cancer Squamous skin cancer

Metabolic syndrome

Malignant melanoma

2.2 × 3.8 × 3.1

central necrotic lesion with margin contrast enhancement

11.619

45.586

none

none

none

7.59 / 5.22

14

15

vertigo

yes

headache

Left cerebellum

Meningeoma Grade I

TIA prior to admission

3.5 × 4.2 × 3.9

solid with homogeneously moderate contrast enhancement

26.960

8.591

none

none

yes

11.0 / 6.0

15

15

hemiparesis right side, unsteadiness

yes

none

Left parietal

Glioblastoma

Hypertension

3.6 × 5.3 × 4.6

central necrotic lesion with margin contrast enhancement

50.717

85.340

none

none

none

8.0 / 8.1

16

14

hemiparesis left side, focal seizures, neurocognitive maladjustment

no

none

Bilateral Corpus Callosum

Non - Hodgkin Lymphoma B-cell type

Delusional disorder

5.2 × 3.5 × 2.3

solid with inhomogeneously contrast enhancement

31.731

196.777

none

none

none

8.34 / 8.16

17

14

hemiparesis left side, neurocognitive deficits

yes

headache

Right Parieto-occipito-temporal

Metastasis

Schizophrenia Lung carcinoma

7.6 × 6.0 × 5.7

central necrotic lesion with margin contrast enhancement

177.348

18.703

14 mm

yes

yes

- / 10.67

18

15

gerstmann syndrome, neurocognitive deficits

no

none

Left parieto-occipital left with infiltration of Splenium Corpus callosum

Non - Hodgkin Lymphoma B-cell type

Coronary atherosclerosis

5.8 × 5.2 × 3.6

central necrotic lesion with thick margin contrast enhancement

36.495

231.438

15 mm

none

yes

9.08 / 11.00

19

15

neurocognitive deficits, incoordination

yes

headache

Right frontal right side with infiltration of the thalamus

Astrocytoma Grade III

None

6.1 × 8.0 × 8.8

central necrotic and cystic wide spreading, diffuse lesion with only punctual contrast enhancement

220.271

25.399

13 mm

none

yes

6.0 / 7.5

20

15

none

yes

headache

Right occipito-temporal

Metastasis

Pancoast tumor

2.2 × 2.9 × 3.1

solid with inhomogeneously contrast enhancement

11.299

238.269

16 mm

none

none

14.5 / -

  1. Abbr.: GCS Glasgow Coma Scale, ICH intracranial hypertension, ICP Intracranial Pressure